Henoch S. Hong

Merck (Germany) — Germany

Medicine · Health Sciences

17h-index1.8kcitations47works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(14), Immune Cell Function and Interaction(14), Immunotherapy and Immune Responses(12), Single-cell and spatial transcriptomics(7), T-cell and B-cell Immunology(6)

Publications45 total

Genomic and immune landscape of recurrent and/or metastatic squamous cell carcinoma of the head and neck progressing on anti-PD1 treatment
Cancer Immunology Research·2026Open Access
Comprehensive characterization of early-stage Non-Small Cell Lung cancers with multi-modal data integration
2025Open Access
Cellohood: multi-granular discovery of cellular neighborhoods with a permutation-invariant set transformer auto-encoder
2025Open Access
Multi-modal image analysis for large-scale cancer tissue studies within IMMUcan
Universität Zürich, ZORA·2025Open Access
Multi-modal image analysis for large-scale cancer tissue studies within IMMUcan
Cell Reports Methods·2025· 1 citedOpen Access
Mechanisms of resistance to anti-PD1 treatment in recurrent and/or metastatic squamous cell carcinoma of the head and neck: A multi-omics IMMUCAN/EORTC analysis.
Journal of Clinical Oncology·2025
Abstract 1177: Tumor-associated macrophages and clinical outcomes to immunotherapy
Cancer Research·2025
Multi-modal image analysis for large scale cancer tissue studies within IMMUcan
2025· 3 citedOpen Access
A luminescence-based point-of-care HIV viral load test for antiretroviral therapy monitoring
Lab on a Chip·2025
257P Spatial predictors of pathologic complete response to neoadjuvant chemotherapy using imaging mass cytometry in the IMMUcan TNBC cohort
Annals of Oncology·2024Open Access
1P Integrated data analysis within IMMUcan identifies prognostic features of early NSCLC
Immuno-Oncology Technology·2023Open Access
176P Multiplex-immunoflourescence spatial patterns to predict triple-negative breast cancer molecular subtypes in the IMMUcan study
Immuno-Oncology Technology·2023Open Access
202P Discovery of immunological cellular neighborhoods from protein markers in spatial tumor data
Immuno-Oncology Technology·2023Open Access
179P Integrating multiplex immunofluorescence with gene expression data in the IMMUcan HER2-positive breast cancer cohort
Immuno-Oncology Technology·2023Open Access
2266P IMMUcan consortium: Focus on the first results of the non-small cell lung cancer (NSCLC) cohort
Annals of Oncology·2023· 3 citedOpen Access
Abstract 4522: Pathologic complete response rate across triple negative breast cancer subtypes in the IMMUcan study
Cancer Research·2023
Yes, IMMUcan! Unraveling the human tumor microenvironment
Immuno Oncology Insights·2021· 4 cited
Abstract 2756: A toolbox enabling a data-driven selection of regions of interest in tumor tissue sections for imaging mass cytometry analysis
Cancer Research·2021· 1 cited
97TiP Identification of therapeutic targets in patients with squamous cell carcinoma of the head and neck who progress on or after anti-PD-(L)1 therapy: An IMMUcan sub-project
Annals of Oncology·2020· 1 citedOpen Access
Abstract 1699: IMMUcan: Broad cellular and molecular profiling of the human tumor microenvironment
Cancer Research·2020
page 1 of 3Next →

Frequent Co-authors

Robin Liechti(15), Marie Morfouace(14), Ulrike Gnad-Vogt(11), Sven D. Koch(11), Sylvie Rusakiewicz(11), Mariola Fotin‐Mleczek(10), Bernd Bodenmiller(10), Nils Eling(9), Karl‐Josef Kallen(8), Birgit Scheel(8), Nupur Bhatnagar(8), Reinhold E. Schmidt(8), Dirk Meyer‐Olson(7), Michelle Daniel(7), Daniel Schulz(7), Flavia Marzetta(7), Andreas Schröder(6), Johanna M. Eberhard(6), Matthias Ballmaier(6), Bruno Palau Fernandez(6)